Refine by
Colon Articles & Analysis
158 news found
Summary Dentists and surgeons devote their professional lives to improving patient health, often engaging in complex procedures that require precision, concentration, and prolonged static or awkward positioning. However, inadequate ergonomics can result in chronic pain, musculoskeletal disorders (MSDs), fatigue, and shortened careers, with studies indicating that up to 80% of these professionals ...
Celecoxib is used to manage symptoms of various arthritis forms and also for familial adenomatous polyposis (FAP) to prevent precancerous polyps in the colon. With EP/USP/JP standard, Protheragen-ING’s celecoxib meets global pharmacopoeia standards. ...
Infections of the blood, urinary tract, and lungs, or in wounds in other parts of the body can all be caused by Acinetobacter baumannii. It can also colonize or live in a person without causing infections or symptoms, especially in respiratory secretions or open wounds, according to the CDC. ...
Colorectal cancer affects the colon or rectum and is on the rise among young adults. Lifestyle factors like diet and physical inactivity may contribute to its incidence. ...
Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are on breathing machines · have devices such as catheters · have open wounds from surgery · are in intensive care units · have prolonged hospital stays Infections of the blood, urinary tract, and lungs, or in ...
Infections of the blood, urinary tract and lungs, or in wounds in other parts of the body can all be caused by Acinetobacter baumannii. It can also colonize or live in a person without causing infections or symptoms, especially in respiratory secretions or open wounds reports the CDC. ...
We report that opioids from the inflamed colon activate δ-opioid receptors (DOPr) in endosomes of nociceptors. Biopsy samples of inflamed colonic mucosa from patients and mice with colitis released opioids that activated DOPr on nociceptors to cause a sustained decrease in excitability. DOPr agonists inhibited mechanically sensitive colonic ...
CDC even warns that patients and residents in healthcare facilities often remain colonized with C. auris for many months, perhaps indefinitely, even after acute infection (if present) has been treated and resolves. ...
” “We need to have prevention modalities that can really stop the spread of infectious diseases and deadly pathogens and so what we would like is additional potential drugs that could be brought to bear so that we could further reduce and maybe even eliminate the risk of that colonization becoming an infection in an individual or that ...
SKOUT demonstrated a 27% relative increase in the detection of adenomas per colonoscopy, with an average of one additional adenoma resected for every 4.5 patients examined. Importantly, in the proximal colon, SKOUT demonstrated a 44% relative increase in 5-9 mm polyp detection, and a 29% relative increase in 5-9 mm polyp detection overall.1 These results validate the need for ...
SEngine’s CLIA-certified PARIS Test generates actionable drug sensitivity reports for patients and is applicable to all solid tumors including colon, breast, lung, ovarian and pancreatic cancer. For cancers where a treatment path is not clear, such as recurrent and/or rare cancers, the PARIS Test provides crucial information to help improve outcomes for cancer patients. ...
Up to 30% of the general population is nasally colonized with S. aureus,[ii] significantly increasing the risk of surgery-related infections. ...
There is potential for expansion beyond lung and brain cancer to other visceral cancers such as to breast, liver, colon, and others. Needs Addressed Non-small cell lung cancer (NSCLC) is the leading cause of cancer death and second most diagnosed cancer in the US. ...
The agency also warns that patients and residents in healthcare facilities often remain colonized with C. auris for many months, perhaps indefinitely, even after acute infection (if present) has been treated and resolves. ...
SEngine's CLIA certified PARIS® Test generates actionable drug sensitivity reports for patients and is applicable to all solid tumors including colon, breast, lung, ovarian and pancreatic cancer. SEngine is also utilizing its precision oncology platform to inform drug discovery via strategic collaborations with biopharmaceutical, and pharma companies as well as, top cancer ...
” The company also believes that there is an urgent clinical need for surface-protected devices like the CeraShield™ ETT designed to combat both bacterial and fungal colonization—including deadly fungal threats such as Candida auris, an emerging highly lethal fungal pathogen recognized by the Centers for Disease Control and Prevention as a “serious global ...
C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon as it travels naturally along the gastrointestinal tract. C-Scan is non-invasive and requires no sedation. ...
Hayes joins an accomplished CAB with expertise in colon, breast, and lung cancers, as well as immuno-therapies. About Xilis Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports drug discovery and development for ...
SER-155 is a cultivated investigational microbiome therapeutic rationally designed to improve clinical outcomes in patients undergoing HSCT by restoring colonization resistance to pathobionts, promoting epithelial barrier integrity, and reducing colonic inflammation. ...
The second poster, entitled Development and Characterization of an opioid-induced constipation (OIC) model in swine: use of G-Tech wireless non-invasive patches to monitor colonic myoelectrical activity (CMA), reported on a study performed by researchers from UCLA and G-Tech. ...